Cheap small caps on book value: the widest spread in our data
Among non-financial companies under $2 billion, the fifth cheapest on price-to-book at each annual report beat the most expensive fifth by a wide margin over the next year — and by more in sell-offs. This is the classic small-value premium, and it is the strongest thing our screens can measure.
- Universe: 657 U.S. companies with ten-plus years of prices (8,703 company-years). Non-financials under $2B market cap at the time. Lowest price-to-book = top fifth.
- Point in time: factor values from the latest fiscal year known on each 10-K filing date; price = first close on or after the filing.
- Outcome: total return over the next 12 and 36 months minus the S&P 500, and minus small caps (IWM) for 12 months; companies ranked into fifths within each filing year; market state = S&P ≥10% below its one-year high on the entry day.
- Limits: survivorship-tilted, small-cap-heavy universe; no costs; the spread between fifths is the finding, the levels are not.
Average twelve-month return minus the S&P 500 by fifth, best-scoring first. Medians in grey.
| Market state at entry | Best fifth | Worst fifth | Spread |
|---|---|---|---|
| Sell-off (S&P ≥10% off high) | +57.6 pts n 89 | +8.4 pts | +49.2 pts |
| Calm | +13.2 pts n 626 | −0.3 pts | +13.5 pts |
| Sector (SEC group) | Company-years | Best fifth, 12 mo | Worst fifth | Spread | Read |
|---|---|---|---|---|---|
| Industrials & manufacturing | 1,275 | +18.1 pts n 256 | +2.4 pts | +15.8 pts | Sorts well |
| Services | 331 | +17.3 pts n 41 | −3.7 pts | +20.9 pts | Sorts well |
| Tech hardware & semis | 326 | +11.0 pts n 64 | −0.9 pts | +11.9 pts | Sorts well |
| Retail & consumer | 208 | +22.4 pts n 46 | −6.4 pts | +28.8 pts | Sorts well |
| Medical devices | 207 | +7.7 pts n 16 | −4.6 pts | +12.3 pts | Too few to say |
| Other | 166 | +11.8 pts n 64 | +13.1 pts | −1.4 pts | Does not sort |
| Energy | 163 | +24.6 pts n 49 | −10.1 pts | +34.7 pts | Sorts well |
| Biotech & pharma | 158 | +62.0 pts n 26 | +11.6 pts | +50.4 pts | Sorts well |
| Finance & real estate | 157 | +2.3 pts n 29 | −8.6 pts | +10.8 pts | Sorts well |
| Software & IT services | 139 | +16.3 pts n 25 | +2.0 pts | +14.3 pts | Sorts well |
The same screen, live — every filter re-tested as you change it
| Market state at entry | Company-years | vs S&P 12 mo | vs small caps |
|---|---|---|---|
| Calm ◀ today | 913 | +11.0 pts t 5.0 | +13.2 pts |
| Sell-off (S&P ≥10% off high) | 142 | +56.1 pts t 4.1 | +50.5 pts |
| Sector (SEC group) | n | vs S&P 12 mo | 3 yrs / yr |
|---|---|---|---|
| Industrials & manufacturing | 396 | +15.4 pts t 4.1 | −1.4 pts |
| Tech hardware & semis | 87 | +11.0 pts t 1.3 | +4.3 pts |
| Other | 86 | +11.6 pts t 1.9 | +6.9 pts |
| Services | 75 | +12.7 pts t 2.3 | +13.0 pts |
| Retail & consumer | 70 | +18.8 pts t 2.0 | +12.3 pts |
| Energy | 53 | +22.1 pts t 1.7 | −0.8 pts |
| Construction | 49 | +14.4 pts t 1.7 | −2.5 pts |
| Finance & real estate | 43 | −5.6 pts t -1.0 | −7.6 pts |
| Biotech & pharma | 39 | +60.4 pts t 1.8 | +12.2 pts |
| Software & IT services | 35 | +39.9 pts t 1.8 | +1.2 pts |
| Medical devices | 25 | +17.3 pts t 1.0 | +21.1 pts |
Holds up out of sample? Before 2018: +13.5 pts (n 466, t 6.0). From 2018: +19.9 pts (n 589, t 4.4). Same sign in both halves.
| Year | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| vs S&P | +17 pts | +8 pts | +15 pts | +22 pts | +0 pts | −1 pts | +25 pts | +15 pts | −0 pts | −14 pts | +106 pts | +6 pts | +16 pts | −7 pts | −6 pts | +19 pts |
| n | 6 | 24 | 80 | 82 | 60 | 67 | 87 | 60 | 53 | 74 | 104 | 50 | 55 | 80 | 89 | 84 |
Read the research behind this screen: Cheap small caps on book value: the widest spread in our data → · Test your own combination in the Screen Lab →
Our model values are recomputed daily but were never stored historically, so this band cannot be backtested honestly yet. Daily snapshots began 2026-09-10; a true record accrues from there. Until then the nearest tested cousin is shown — cheap on book value — and labelled as a proxy. Point-in-time: each entry is one company bought at the first close after its 10-K filing date, using only filings available that day, held 12 months; result = total return minus SPY over the same months (vs IWM for 12 months; 3-yr annualised). Survivorship-tilted universe; no costs; read spreads, not levels. Educational, hypothetical, before costs.
SAVNG is an educational research publication, not a Registered Investment Adviser. Everything here is general-circulation information produced by an automated pipeline — the same for every reader — and is not personalized investment advice, an offer, or a recommendation to buy or sell any security. Any performance figure is hypothetical; past performance does not predict future results. Details.
Published by SAVNG Research. Every figure on this page is read from the study data at render time; if the study changes, the page changes with it.